Role of CYP1A2 in the hepatotoxicity of acetaminophen : Investigations using Cyp1a2 null mice
Acetaminophen (APAP) is known to cause centrilobular hepatic necrosis under overdose conditions. This is thought to be mediated via the P450-generated reactive intermediate N-acetyl-p-benzoquinone imine (NAPQI). Initially, NAPQI is detoxified by conjugation with glutathione (GSH), but once GSH is de...
Saved in:
Published in: | Toxicology and applied pharmacology Vol. 153; no. 1; pp. 102 - 108 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
San Diego, CA
Elsevier
01-11-1998
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Acetaminophen (APAP) is known to cause centrilobular hepatic necrosis under overdose conditions. This is thought to be mediated via the P450-generated reactive intermediate N-acetyl-p-benzoquinone imine (NAPQI). Initially, NAPQI is detoxified by conjugation with glutathione (GSH), but once GSH is depleted, NAPQI reacts more extensively with hepatic proteins leading to hepatocellular damage. The P450 isoforms thought to be responsible for APAP hepatotoxicity in humans are CYP2E1, CYP1A2, and CYP3A4, and thus, we have investigated the effect of murine Cyp1a2 on APAP hepatotoxicity using Cyp1a2 knockout mice (Liang et al., Proc. Natl. Acad. Sci. USA 93, 1671-1676, 1996). Doses of 250 mg/kg were markedly hepatotoxic in these mice, and surprisingly, deaths only occurred in the knock-out and heterozygote mice over a 24-h period after dosing. Furthermore, there were no significant differences among survivors of any genotype in serum ALT concentrations, a well correlated indicator of APAP hepatotoxicity in mice. Finally, no differences were observed in the urinary metabolites excreted ove the 24-h period, including those derived from GSH conjugation of the major reactive metabolite NAPQI. Consistent with the effects on hepatotoxicity and metabolism, 2 h after hepatotoxic doses (500 mg/kg, i.p.) of APAP no significant differences were observed in total whole liver homogenate nonprotein thiol concentrations among the three genotypes even though hepatic thiols were decreased compared to control animals (> 90%). In addition, when the liver cytosol and microsome samples were examined by immunoblotting for the presence of APAP-protein adducts using a specific antiserum, there were no observable differences in either the intensity of staining or in the spectrum of adducts formed between APAP-dosed mice of any genotype. The cumulative data suggest that Cyp1a2 doses not play a significant role in APAP hepatotoxicity in these mice. |
---|---|
AbstractList | Acetaminophen (APAP) is known to cause centrilobular hepatic necrosis under overdose conditions. This is thought to be mediated via the P450-generated reactive intermediate N-acetyl-p-benzoquinone imine (NAPQI). Initially, NAPQI is detoxified by conjugation with glutathione (GSH), but once GSH is depleted, NAPQI reacts more extensively with hepatic proteins leading to hepatocellular damage. The P450 isoforms thought to be responsible for APAP hepatotoxicity in humans are CYP2E1, CYP1A2, and CYP3A4, and thus, we have investigated the effect of murine Cyp1a2 on APAP hepatotoxicity using Cyp1a2 knockout mice (Liang et al., Proc. Natl. Acad. Sci. USA93, 1671-1676, 1996). Doses of 250 mg/kg were markedly hepatotoxic in these mice, and surprisingly, deaths only occurred in the knock-out and heterozygote mice over a 24-h period after dosing. Furthermore, there were no significant differences among survivors of any genotype in serum ALT concentrations, a well correlated indicator of APAP hepatotoxicity in mice. Finally, no differences were observed in the urinary metabolites excreted over the 24-h period, including those derived from GSH conjugation of the major reactive metabolite NAPQI. Consistent with the effects on hepatotoxicity and metabolism, 2 h after hepatotoxic doses (500 mg/kg, ip) of APAP no significant differences were observed in total whole liver homogenate nonprotein thiol concentrations among the three genotypes even though hepatic thiols were decreased compared to control animals (>90%). In addition, when the liver cytosol and microsome samples were examined by immunoblotting for the presence of APAP-protein adducts using a specific antiserum, there were no observable differences in either the intensity of staining or in the spectrum of adducts formed between APAP-dosed mice of any genotype. The cumulative data suggest that Cyp1a2 does not play a significant role in APAP hepatotoxicity in these mice. Copyright 1998 Academic Press. Acetaminophen (APAP) is known to cause centrilobular hepatic necrosis under overdose conditions. This is thought to be mediated via the P450-generated reactive intermediate N-acetyl-p-benzoquinone imine (NAPQI). Initially, NAPQI is detoxified by conjugation with glutathione (GSH), but once GSH is depleted, NAPQI reacts more extensively with hepatic proteins leading to hepatocellular damage. The P450 isoforms thought to be responsible for APAP hepatotoxicity in humans are CYP2E1, CYP1A2, and CYP3A4, and thus, we have investigated the effect of murine Cyp1a2 on APAP hepatotoxicity using Cyp1a2 knockout mice (Liang et al., Proc. Natl. Acad. Sci. USA 93, 1671-1676, 1996). Doses of 250 mg/kg were markedly hepatotoxic in these mice, and surprisingly, deaths only occurred in the knock-out and heterozygote mice over a 24-h period after dosing. Furthermore, there were no significant differences among survivors of any genotype in serum ALT concentrations, a well correlated indicator of APAP hepatotoxicity in mice. Finally, no differences were observed in the urinary metabolites excreted ove the 24-h period, including those derived from GSH conjugation of the major reactive metabolite NAPQI. Consistent with the effects on hepatotoxicity and metabolism, 2 h after hepatotoxic doses (500 mg/kg, i.p.) of APAP no significant differences were observed in total whole liver homogenate nonprotein thiol concentrations among the three genotypes even though hepatic thiols were decreased compared to control animals (> 90%). In addition, when the liver cytosol and microsome samples were examined by immunoblotting for the presence of APAP-protein adducts using a specific antiserum, there were no observable differences in either the intensity of staining or in the spectrum of adducts formed between APAP-dosed mice of any genotype. The cumulative data suggest that Cyp1a2 doses not play a significant role in APAP hepatotoxicity in these mice. |
Author | KALHORN, T NELSON, S. D BRUSCHI, S. A NEBERT, D. W EATON, D. L TONGE, R. P KELLY, E. J |
Author_xml | – sequence: 1 givenname: R. P surname: TONGE fullname: TONGE, R. P organization: Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195-7631, United States – sequence: 2 givenname: E. J surname: KELLY fullname: KELLY, E. J organization: Department of Environmental Health, University of Washington, Seattle, Washington 98195-7631, United States – sequence: 3 givenname: S. A surname: BRUSCHI fullname: BRUSCHI, S. A organization: Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195-7631, United States – sequence: 4 givenname: T surname: KALHORN fullname: KALHORN, T organization: Department of Pharmaceutics, University of Washington, Seattle, Washington 98195-7631, United States – sequence: 5 givenname: D. L surname: EATON fullname: EATON, D. L organization: Department of Environmental Health, University of Washington, Seattle, Washington 98195-7631, United States – sequence: 6 givenname: D. W surname: NEBERT fullname: NEBERT, D. W organization: Department of Environmental Health, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0056, United States – sequence: 7 givenname: S. D surname: NELSON fullname: NELSON, S. D organization: Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195-7631, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1668048$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9875304$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kM9LAzEQhYNUtFWv3oQcxNvWmU3MZr2V4o-CoIiCHqTMplkb2U3WJiv2v7di8TSH7-Px3ozYwAdvGTtGGCOAOk9E3RjLUo_1hRQ7bIhQqgyEEAM2BJCYAeiXfTaK8QMASilxj-2VurgQIIfs7TE0loeaT18fcJJz53laWr60HaWQwrczLq1_ORmbqHU-dEvr-SWf-S8bk3un5IKPvI_Ov_PpukPKue-bhrfO2EO2W1MT7dH2HrDn66un6W12d38zm07usi5XKmVWlGqBWFVUa6uwEDVomxtELcrNGk01LmQp1MKQKbAqpEWqcsJC6VpRBeKAnf3ldqvw2W96zVsXjW0a8jb0cY5aopTwK55sxb5q7WLerVxLq_V8-48NP91yioaaekXeuPivoVIapBY_EQFwLg |
CODEN | TXAPA9 |
ContentType | Journal Article |
Copyright | 1999 INIST-CNRS |
Copyright_xml | – notice: 1999 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM 7U7 C1K |
DOI | 10.1006/taap.1998.8543 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Toxicology Abstracts Environmental Sciences and Pollution Management |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Toxicology Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | Toxicology Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1096-0333 |
EndPage | 108 |
ExternalDocumentID | 9875304 1668048 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article Comparative Study |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: GM32165 – fundername: NIEHS NIH HHS grantid: ES07033 – fundername: NIGMS NIH HHS grantid: GM25418 |
GroupedDBID | --- --K --M .55 .GJ .HR .~1 08R 0R~ 123 1B1 1RT 1~. 1~5 29Q 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKC AAIKJ AAKOC AALRI AAMNW AAOAW AAPBV AAQFI AAQXK AATCM AAUGY AAXUO ABEFU ABFNM ABFRF ABFYP ABLST ABMAC ABPIF ABPTK ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD AEBSH AEFWE AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHEUO AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AKIFW ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLECG BLXMC C45 CAG COF CS3 DM4 EBS EFBJH EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HZ~ IHE IQODW J1W KCYFY KOM LG5 M33 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SDP SES SEW SPCBC SPT SSJ SSP SSZ T5K TEORI TWZ UHS WH7 WUQ X7M XJT XPP Y6R YCJ ZGI ZKB ZMT ZU3 ZXP ~G- ~KM AAXKI ABJNI AFJKZ AKRWK CGR CUY CVF ECM EIF HVGLF NPM 7U7 C1K |
ID | FETCH-LOGICAL-p266t-e396d11bbaf8e6173f08e2c118390968af1d4936dcac71b74e1ab2a1768f6ab03 |
ISSN | 0041-008X |
IngestDate | Fri Oct 25 09:50:42 EDT 2024 Sat Sep 28 07:32:28 EDT 2024 Sun Oct 29 17:07:04 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Isozyme Toxicity Cytochrome P450 Liver Rodentia Silent allele Vertebrata Paracetamol Mammalia Analgesic Mouse Animal Deletion Digestive diseases Mutation Mechanism of action |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p266t-e396d11bbaf8e6173f08e2c118390968af1d4936dcac71b74e1ab2a1768f6ab03 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 9875304 |
PQID | 18414400 |
PQPubID | 23462 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_18414400 pubmed_primary_9875304 pascalfrancis_primary_1668048 |
PublicationCentury | 1900 |
PublicationDate | 1998-11-01 |
PublicationDateYYYYMMDD | 1998-11-01 |
PublicationDate_xml | – month: 11 year: 1998 text: 1998-11-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | San Diego, CA |
PublicationPlace_xml | – name: San Diego, CA – name: United States |
PublicationTitle | Toxicology and applied pharmacology |
PublicationTitleAlternate | Toxicol Appl Pharmacol |
PublicationYear | 1998 |
Publisher | Elsevier |
Publisher_xml | – name: Elsevier |
SSID | ssj0009441 |
Score | 1.8922108 |
Snippet | Acetaminophen (APAP) is known to cause centrilobular hepatic necrosis under overdose conditions. This is thought to be mediated via the P450-generated reactive... |
SourceID | proquest pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 102 |
SubjectTerms | Acetaminophen - analogs & derivatives Acetaminophen - metabolism Acetaminophen - toxicity Acetaminophen - urine Alanine Transaminase - blood Analgesics, Non-Narcotic - metabolism Analgesics, Non-Narcotic - toxicity Animals Biological and medical sciences Chemical and Drug Induced Liver Injury Cytochrome P-450 CYP1A2 - deficiency Cytochrome P-450 CYP1A2 - physiology Drug toxicity and drugs side effects treatment Liver - drug effects Liver - enzymology Liver Diseases - enzymology Liver Diseases - metabolism Male Medical sciences Mice Mice, Knockout Pharmacology. Drug treatments Toxicity: digestive system |
Title | Role of CYP1A2 in the hepatotoxicity of acetaminophen : Investigations using Cyp1a2 null mice |
URI | https://www.ncbi.nlm.nih.gov/pubmed/9875304 https://search.proquest.com/docview/18414400 |
Volume | 153 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Ra9swEBZr-zIYo-tWlq3d9DD6snqzbMWW-xYyl2wrWWhdyGBgJEtigc02jQPtv-_JcqKYMbY97MUYBQvj78vp7vTdCaE3tBCxFER5CWfco1JoTyTS91QEzoNmJGTKpLInV_F0zj6kNHWpbDf2X5GGMcDaVM7-A9qbSWEA7gFzuALqcP0r3C87ueD464yMgrWMcQKrTlM11e2i6DQYo0I1_OeiNH0FWnXHVscNI5-xWoLxXU148HYKgapR2Pd0Q5mZzbVw4p0_W7tm2Jt0fVaV9gj3S1dP9tlsGbQQp25vCqgG4XarMLhyiwH_8b2youPMZSnasj2yyVJ0lpfCgN8eI-wsr-0T3KOYtaPED7aWZNK2fvjV2oPFADgazmtTdMnesaFt-dRvqz39kp9fX1zkWTrPdtBeABYJDOLe6GM6_-T6M1NqD1fsXnPd39OP3vfnN-JZvoT_j7YHn_w-Mmk9lGwfPe5CCzyynHiCHqjyAJ3MLBx3pzhzpXbLU3yCZ1tAHaBHNoGLbV3aU_TNEAlXGlsi4UWJgUi4TyTze49IZ7hPI9zSCFsaYUMjbGj0DF2fp9l44nVHcXg1eHCNp8IkkoQIwTVT4PSG2mcqKIjxryEIZlwTSZMwkgUvYiJiqggXAScQzOqICz88RLtlVarnCDMqJEzAh3IYU19HQsWyoBIc-4SFQugBOu594Ly2bVdyEkUM1psBer3-4DmYQrO_xUtVrZY5YdRIFfwBOrQ4bB5NTFTu0xd_fPQleujYe4R2m5uVOkY7S7l61THmHnyihW8 |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+CYP1A2+in+the+Hepatotoxicity+of+Acetaminophen%3A+Investigations+Using+Cyp1a2+Null+Mice&rft.jtitle=Toxicology+and+applied+pharmacology&rft.au=Tonge%2C+R+P&rft.au=Kelley%2C+E+J&rft.au=Bruschi%2C+SA&rft.au=Kalhorn%2C+T&rft.date=1998-11-01&rft.issn=0041-008X&rft.volume=153&rft.issue=1&rft.spage=102&rft.epage=108&rft_id=info:doi/10.1006%2Ftaap.1998.8543&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0041-008X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0041-008X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0041-008X&client=summon |